New York City-based Montefiore Einstein Comprehensive Cancer Center is diagnosing more patients with stage 1 lung cancer than stage 4 for the first time in decades. In 2024, stage 4 lung cancer diagnoses fell to 34% while stage 1 diagnoses…
The Latest
Expanding screening criteria set by the U.S. Preventive Services Task Force would increase lung cancer detection from 35.1% to 62.1%, according to a study published Nov. 20 in JAMA Network Open. Researchers analyzed data from 997 lung cancer patients diagnosed…
Chicago-based Northwestern Medicine’s Canning Thoracic Institute has launched the Lung Health Center, aimed at early detection of multiple lung, heart and bone conditions. The center was established through a gift from Rita and John Canning, according to a Nov. 20…
In September, Peoria, Ill.-based OSF HealthCare appointed Jun Zhang, MD, PhD, as vice president of oncology research for the OSF Cancer Institute. In the role, Dr. Zhang oversees the health system’s clinical trial program — the OSF Breakthrough Treatment Center.…
Newark, Del.-based ChristianaCare has opened an organoid core center within its Helen F. Graham Cancer Center & Research Institute. The laboratory, established through the Cawley Center for Translational Cancer Research, is the first of its kind to be launched within…
Two National Cancer Institute-designated comprehensive cancer centers have been recognized by the College of Healthcare Information Management Executives for a commitment to digital health excellence. Tampa, Fla.-based Moffitt Cancer Center and Buffalo, N.Y.-based Roswell Park Comprehensive Cancer Center both earned…
Houston-based University of Texas MD Anderson Cancer Center has launched a $2.5 billion philanthropic campaign, the largest fundraising effort in the center’s 84-year history. Initial donor support has raised $1.9 billion toward the $2.5 billion goal, according to a Nov.…
Oklahoma City-based OU Health has broken ground on a new Stephenson Cancer Center facility on the University of Oklahoma’s Schusterman Center campus in Tulsa. Expected to open in 2028, the new facility will house 70 exam rooms, 45 infusion spaces,…
Two studies out of Rutgers Cancer Institute and RWJBarnabas Health, both based in New Brunswick, N.J., show the potential for novel T-cell therapies to successfully achieve remission and tumor regression among patients with HPV-related cancers. Both studies were led by…